AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)

Clinical trial NCT05578430 · UNKNOWN

Trial details

NCT number: NCT05578430
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Hepatocellular Carcinoma

Start date: 2023-01-01
Primary completion: 2025-01-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.